E-Leviate Pharma
PrivateLast Round
Seed
Dec 18, 2025
Total Funding Raised
$500,000
Company Overview
E-Leviate Pharma operates in Healthcare & Life Sciences and is based in Auckland. Its latest recorded funding round was a Seed round in December 2025.
E-Leviate Pharma is a therapeutic devices company that develops a novel drug-device for a range of common gynecological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
E-Leviate Pharma Comparables
Compare E-Leviate Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FemTherapeutics | 83% | |
| Reia | 80% | |
| Epigenuity LLC | 77% |
For institutional investors. Book with your work email.
E-Leviate Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
E-Leviate Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Icehouse Ventures | Seed |
| SOUL Capital | Seed |
| Outset Ventures | Pre Seed, Seed |
| Nuance Connected Capital | Seed |
| Clare Ventures | Pre Seed, Seed |
E-Leviate Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about E-Leviate Pharma's valuation, stock price, and market status.
Is E-Leviate Pharma a public or private company?
E-Leviate Pharma is a private company.
What is the current stock price of E-Leviate Pharma?
E-Leviate Pharma is a private company, so its shares have no public market price. Caplight tracks E-Leviate Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is E-Leviate Pharma worth (valuation)?
Valuation information for E-Leviate Pharma is not publicly available.
Can I buy E-Leviate Pharma stock?
E-Leviate Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was E-Leviate Pharma's last funding round?
E-Leviate Pharma's most recent funding round was Seed on December 18, 2025.
Who are the main investors in E-Leviate Pharma?
Key investors in E-Leviate Pharma include Outset Ventures.
Will E-Leviate Pharma IPO soon?
No public IPO plans have been announced for E-Leviate Pharma.
How can I track E-Leviate Pharma secondary market activity?
Caplight tracks bids, offers, and trades in E-Leviate Pharma's shares on secondary markets.